Sophiris Bio Company Profile (NASDAQ:SPHS)

About Sophiris Bio

Sophiris Bio, Inc., formerly Protox Therapeutics Inc., is a Canada-based biopharmaceutical company focused on the research, development and commercialization of products for the treatment of urological diseases. The Company has operations based in San Diego developing a treatment for benign prostatic hyperplasia (benign prostatic hyperplasia (BPH) or enlarged prostate). The Company has partnered with Kissei Pharmaceuticals for the development and commercialization of PRX302 in Japan. Sophiris Bio, Inc. is advancing a pipeline of receptor targeted fusion proteins based on three complementary technology platforms: PORxin, INxin and HUMxin. It focuses on diseases of the prostate via its PORxin platform candidate, PRX302, which has completed three clinical trials for the treatment of BPH, as well as two clinical trials for the treatment of localized recurrent prostate cancer.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drugs - Generic
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: SPHS
CUSIP:

Key Metrics:

Previous Close: $3.08
50 Day Moving Average: $3.544
200 Day Moving Average: $2.479
52-Week Range: $0.67 - $8.55
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -6.22
P/E Growth: 0.000
Market Cap: $70.00M
Outstanding Shares: 22,618,000
Beta: 1.78

Profitability:

Return on Equity: -826.95%
Return on Assets: -144.07%

Debt:

Debt-to-Equity Ratio: 3.56%
Current Ratio: 3.02%
Quick Ratio: 3.02%

Additional Links:

Companies Related to Sophiris Bio:

Consensus Ratings for Sophiris Bio (NASDAQ:SPHS) (?)

Ratings Breakdown:	4 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$6.50 (109.00% upside)

Analysts' Ratings History for Sophiris Bio (NASDAQ:SPHS)

Show:

Date	Firm	Action	Rating	Price Target
9/15/2016	Roth Capital	Initiated Coverage	Buy	$8.00
8/30/2016	Piper Jaffray Cos.	Initiated Coverage	Overweight -> Overweight	$7.00
8/10/2016	Maxim Group	Boost Price Target	Buy	$4.00 -> $6.00
6/10/2016	Echelon Wealth Partners	Reiterated Rating	Buy	$5.00
12/18/2014	Stifel Nicolaus	Downgrade	Buy -> Hold	$7.00
10/16/2014	Leerink Swann	Initiated Coverage	Outperform	$5.00

(Data available from 9/30/2014 forward)

Earnings History for Sophiris Bio (NASDAQ:SPHS)

Date	Quarter	Consensus Estimate	Actual EPS	Release Link	Conference Call
11/14/2016
5/16/2016	Q1	($0.19)	($0.13)	View	N/A
3/23/2016	Q4		($0.15)	View	N/A
11/16/2015	Q3		($0.22)	View	N/A
5/13/2015		($0.30)	($0.26)	View	N/A
3/10/2015		($0.47)	($0.31)	View	N/A
11/13/2014		($0.54)	($0.49)	View	N/A
5/13/2014	Q114	($0.50)	($0.52)	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Sophiris Bio (NASDAQ:SPHS)

Current Year EPS Consensus Estimate: $-0.51 EPS
Next Year EPS Consensus Estimate: $-0.50 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q3 2016	2	($0.09)	($0.07)	($0.08)
Q4 2016	2	($0.08)	($0.06)	($0.07)

(Data provided by Zacks Investment Research)

Dividend History for Sophiris Bio (NASDAQ:SPHS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Sophiris Bio (NASDAQ:SPHS)

Insider Ownership Percentage: 5.90%
Institutional Ownership Percentage: 5.29%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/15/2014	Boxer Capital, Llc	Major Shareholder	Sell	881,479	$0.61	$537,702.19
11/14/2014	Randall E Woods	Insider	Buy	3,000	$2.43	$7,290.00
9/19/2014	Gerald T Proehl	Director	Buy	10,000	$3.16	$31,600.00
7/10/2014	Randall E Woods	Insider	Buy	1,000	$2.65	$2,650.00
7/9/2014	Randall E Woods	Insider	Buy	1,000	$2.66	$2,660.00
6/6/2014	James L Heppell	Director	Sell	19,231	$2.59	$49,808.29
8/22/2013	Randall E Woods	CEO	Buy	2,500	$4.50	$11,250.00
8/20/2013	Peter T Slover	CFO	Buy	4,680	$4.25	$19,890.00
8/19/2013	Randall E Woods	CEO	Buy	10,000	$4.29	$42,900.00
8/16/2013	Boxer Capital, Llc	Major Shareholder	Buy	1,600,000	$5.00	$8,000,000.00

(Data available from 1/1/2013 forward)

Latest Headlines for Sophiris Bio (NASDAQ:SPHS)

Date	Headline
	Volatile Stocks Under Street Updates- Abbott Laboratories (NYSE:ABT), Sophiris Bio, Inc. (NASDAQ:SPHS) - Street Wise Report (press release) (blog) (NASDAQ:SPHS) streetwisereport.com - September 27 at 7:21 PM
	Under the Microscope: Zeroing in on Shares of Sophiris Bio, Inc ... - Duncan Research (NASDAQ:SPHS) www.duncanindependent.com - September 26 at 7:26 PM
	Sell-Side Predicting Sophiris Bio, Inc. (NASDAQ:SPHS) Stock Will Touch Between $6-8 - Frisco Fastball (NASDAQ:SPHS) friscofastball.com - September 26 at 10:47 AM
	Keen Investors Find News on Sophiris Bio, Inc. (NASDAQ:SPHS) - Duncan Research (NASDAQ:SPHS) www.duncanindependent.com - September 24 at 11:46 AM
	Noticeable Stock: Sophiris Bio, Inc. (SPHS), Cameco Corporation (CCJ) - Newburgh Press (NASDAQ:SPHS) newburghpress.com - September 22 at 11:58 AM
	Sophiris Bio, Inc. :SPHS-US: Earnings Analysis: Q2, 2016 By the Numbers : September 20, 2016 (NASDAQ:SPHS) www.capitalcube.com - September 21 at 11:31 AM
	Neurocrine Biosciences : Generic Drugs Stocks on Investors' Radar -- Zoetis, Sophiris Bio, Rigel Pharma, and Neurocrine Biosciences (NASDAQ:SPHS) www.4-traders.com - September 20 at 11:34 AM
	Pre-Open Stock Movers 09/15: (AERI) (ACRX) (NTWK) Higher; (SQNS) (PAH) (SRPT) Lower (more...) (NASDAQ:SPHS) www.streetinsider.com - September 15 at 11:03 AM
	Sophiris Bio (SPHS) Stock Coverage Initiated at Roth Capital (NASDAQ:SPHS) www.thestreet.com - September 15 at 11:03 AM
	Keen Investors Narrowing Their Focus on Sophiris Bio, Inc. (NASDAQ:SPHS) - Duncan Research (NASDAQ:SPHS) www.duncanindependent.com - September 14 at 7:33 PM
	Sophiris Bio Inc (NASDAQ:SPHS): Bias Vinidcated, Reinforced and Restated - Street Register (NASDAQ:SPHS) streetregister.com - September 14 at 7:33 PM
	HC Stocks News Ring= Sophiris Bio Inc (SPHS), Idera ... - share market updates (press release) (NASDAQ:SPHS) sharemarketupdates.com - September 14 at 7:33 PM
	Sophiris Bio Inc (NASDAQ:SPHS): Bias Vinidcated, Reinforced and Restated (NASDAQ:SPHS) streetregister.com - September 13 at 12:17 PM
	Sophiris Bio, Inc. (NASDAQ:SPHS) are Projected to Reach 6.5, According to Analysts - Frisco Fastball (NASDAQ:SPHS) friscofastball.com - September 12 at 6:58 PM
	Sophiris Bio, Inc. (NASDAQ:SPHS) Shares in Focus As Analysts Agree on a Consensus Target - Frisco Fastball (NASDAQ:SPHS) friscofastball.com - September 12 at 6:58 PM
	SPHS: Initiating on Sophiris Bio, Inc.; Developing Novel Treatments for Urologic Conditions (NASDAQ:SPHS) finance.yahoo.com - September 12 at 6:58 PM
	3 Notable Runners: Thomson Reuters Corporation (TRI), Sophiris Bio, Inc. (SPHS), Brookdale Senior Living Inc. (BKD) - iStreetWire (NASDAQ:SPHS) istreetwire.com - September 8 at 11:15 AM
	Notable Stock's Buzzers: KKR & Co. L.P.(NYSE:KKR), Sophiris Bio Inc (NASDAQ:SPHS), Michaels Companies Inc ... - NYSE Journal (press release) (NASDAQ:SPHS) stockznews.com - September 7 at 11:08 AM
	Is the Price Target of 6.5 To Far Fetched for Sophiris Bio, Inc. (NASDAQ:SPHS)? - Frisco Fastball (NASDAQ:SPHS) friscofastball.com - September 3 at 11:26 AM
	HC Stock News: Sophiris Bio Inc (NASDAQ:SPHS) - share market updates (press release) (NASDAQ:SPHS) sharemarketupdates.com - September 2 at 12:18 PM
	Analyst Upgrades: United Continental Holdings Inc, Sophiris Bio Inc, and VMware, Inc. - Schaeffers Research (blog) (NASDAQ:SPHS) www.schaeffersresearch.com - August 30 at 10:46 AM
	Sophiris Bio Closes Underwritten Public Offering (NASDAQ:SPHS) www.publicnow.com - August 26 at 7:09 PM
	Sophiris Bio Inc. (NASDAQ:SPHS): Sabby Capital Reports Large New Stake (NASDAQ:SPHS) feedproxy.google.com - August 25 at 10:13 PM
	Is Sophiris Bio Inc (NASDAQ:SPHS) About To Announce A Big Pharma Partnership? (NASDAQ:SPHS) streetregister.com - August 25 at 7:45 PM
	Is Sophiris Bio Inc (NASDAQ:SPHS) About To Announce A Big Pharma Partnership? - Street Register (NASDAQ:SPHS) streetregister.com - August 25 at 12:25 PM
	Sophiris Bio Inc. Shares Slide After Stock Offering (NASDAQ:SPHS) sdbj.com - August 24 at 7:15 PM
	SPHS Prices Offering At $4.00/share And Related Warrant (NASDAQ:SPHS) www.rttnews.com - August 24 at 7:15 PM
	Sophiris Bio (SPHS) Prices Common Stock, Warrants Offering for Proceeds of $26M (NASDAQ:SPHS) www.streetinsider.com - August 24 at 7:15 PM
	Active Stock's Momentum: Sophiris Bio Inc (NASDAQ:SPHS), Rite Aid Corporation (NYSE:RAD) - NYSE Journal (press release) (NASDAQ:SPHS) stockznews.com - August 24 at 10:38 AM
	Movers to Watch - Petroleo Brasileiro SA Petrobras (NYSE:PBR), Sophiris Bio Inc (NASDAQ:SPHS) - Money News (press release) (NASDAQ:SPHS) www.newsismoney.com - August 23 at 7:39 PM
	Sophiris Bio Prices Public Offering of Shares and Warrants; Shares Tumble Pre-Market (NASDAQ:SPHS) www.nasdaq.com - August 23 at 12:02 PM
	Sophiris Bio Prices Public Offering of Common Shares and Warrants (NASDAQ:SPHS) www.publicnow.com - August 23 at 12:02 PM
	Sophiris Bio (SPHS) Stock Tumbles on Public Offering (NASDAQ:SPHS) www.thestreet.com - August 23 at 12:02 PM
	Sophiris Bio's stock plunges to pace Nasdaq losers after discounted share offering (NASDAQ:SPHS) www.marketwatch.com - August 23 at 12:02 PM
	Sophiris Bio Announces Proposed Public Offering of Common Shares and Warrants (NASDAQ:SPHS) www.publicnow.com - August 22 at 7:25 PM
	Sophiris Bio shares tank on secondary stock offering (NASDAQ:SPHS) www.marketwatch.com - August 22 at 7:25 PM
	Volatile Session Ends on Positive Note (NASDAQ:SPHS) www.fxstreet.com - August 19 at 10:29 AM
	NASDAQ Index Relatively Benign Today on Low Volatility (NASDAQ:SPHS) www.economiccalendar.com - August 18 at 7:48 PM
	Maxim Raises Price Target For Sophiris Bio Inc (SPHS) Following ... - Smarter Analyst (NASDAQ:SPHS) www.smarteranalyst.com - August 12 at 7:40 PM
	Company Update (NASDAQ:SPHS): Sophiris Bio Inc Reports ... - Smarter Analyst (NASDAQ:SPHS) www.smarteranalyst.com - August 11 at 8:05 PM
	Maxim Raises Price Target For Sophiris Bio Inc (SPHS) Following 2Q Update - Smarter Analyst (NASDAQ:SPHS) www.smarteranalyst.com - August 11 at 8:05 PM
	Company Update (NASDAQ:SPHS): Sophiris Bio Inc Reports Second Quarter 2016 Financial Results and Key ... - Smarter Analyst (NASDAQ:SPHS) www.smarteranalyst.com - August 9 at 7:50 PM
	4:33 pm Sophiris Bioc reports Q2 results, update (NASDAQ:SPHS) finance.yahoo.com - August 9 at 7:50 PM
	Sophiris Bio Reports Second Quarter 2016 Financial Results and Key Business Highlights (NASDAQ:SPHS) www.publicnow.com - August 9 at 7:50 PM
	Stocks Movements to Focus: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , Sophiris Bio, Inc. (NASDAQ:SPHS) - Street Updates (NASDAQ:SPHS) www.streetupdates.com - August 4 at 10:43 AM
	Notable Analyst Views: Sophiris Bio Inc (NASDAQ:SPHS), American Axle & Manufact. Holdings, Inc. (NYSE:AXL) - Review Fortune (NASDAQ:SPHS) reviewfortune.com - August 3 at 7:54 PM
	Sophiris Bio, Inc. (NASDAQ:SPHS) Insider Activities Are in the Air - Review Fortune (NASDAQ:SPHS) reviewfortune.com - August 3 at 7:54 PM
	Stock to keep an eye on: Sophiris Bio, Inc. (NASDAQ:SPHS) - News Oracle (NASDAQ:SPHS) www.newsoracle.com - August 3 at 7:54 PM
	Investors Spotlight: Alere Inc. (NYSE:ALR) , Sophiris Bio, Inc. (NASDAQ:SPHS) - Street Updates (NASDAQ:SPHS) www.streetupdates.com - July 29 at 7:42 PM
	Sophiris Bio, Inc. (NASDAQ:SPHS): Updated Analyst Ratings - Review Fortune (NASDAQ:SPHS) reviewfortune.com - July 29 at 7:42 PM